MedTrace Logo

Effects of Nystatin Suspension Oral Application on Oral Microbial Community

NCT04550546 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-06-15

No results posted yet for this study

Summary

The purpose of this study is to examine the effect of a prescription mouth rinse (Nystatin),an FDA approved drug, on the different types of bacteria in the mouth. Results from this study may help understand the effect that Nystatin oral rinse has on certain types of oral bacteria, which may also cause tooth decay.

Conditions

  • Dental Caries

Interventions

DRUG

Nystatin

600,000 U/mL of nystatin in a rinse suspension

Sponsors & Collaborators

  • University of Rochester

    lead OTHER

Principal Investigators

  • Jin Xiao, DDS, PhD · University of Rochester

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-15
Primary Completion
2022-02-28
Completion
2022-02-28
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04550546 on ClinicalTrials.gov